Sign in or Register   Sign in or Register
  |  

Mouse Anti-CYLD Recombinant Antibody (1E9) (CBMAB-A2037-LY)

The product is antibody recognizes CYLD. The antibody 1E9 immunoassay techniques such as: IF, ELISA.
See all CYLD antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
1E9
Antibody Isotype
IgG2a, κ
Application
IF, ELISA

Basic Information

Immunogen
CYLD (AAH12342, 854 a.a. ~ 953 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Specificity
Human
Antibody Isotype
IgG2a, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
CYLD Lysine 63 Deubiquitinase
Introduction
This gene is encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq]
Entrez Gene ID
Alternative Names
CDMT; CYLD1; CYLDI; EAC; FLJ20180; FLJ31664; FLJ78684; HSPC057; KIAA0849; MFT; MFT1; SBS; TEM; USPL2
Function
Deubiquitinase that specifically cleaves 'Lys-63'- and linear 'Met-1'-linked polyubiquitin chains and is involved in NF-kappa-B activation and TNF-alpha-induced necroptosis (PubMed:18636086, PubMed:26670046, PubMed:27458237, PubMed:26997266, PubMed:27591049, PubMed:29291351, PubMed:18313383).

Plays an important role in the regulation of pathways leading to NF-kappa-B activation (PubMed:12917689, PubMed:12917691).

Contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation (PubMed:12917690).

Negative regulator of Wnt signaling (PubMed:20227366).

Inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules (PubMed:19893491).

Plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis (PubMed:18222923, PubMed:20194890).

Required for normal cell cycle progress and normal cytokinesis (PubMed:17495026, PubMed:19893491).

Inhibits nuclear translocation of NF-kappa-B (PubMed:18636086).

Plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation (PubMed:18636086).

Dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells (By similarity).

Negatively regulates TNFRSF11A signaling and osteoclastogenesis (By similarity).

Involved in the regulation of ciliogenesis, allowing ciliary basal bodies to migrate and dock to the plasma membrane; this process does not depend on NF-kappa-B activation (By similarity).

Ability to remove linear ('Met-1'-linked) polyubiquitin chains regulates innate immunity and TNF-alpha-induced necroptosis: recruited to the LUBAC complex via interaction with SPATA2 and restricts linear polyubiquitin formation on target proteins (PubMed:26997266, PubMed:26670046, PubMed:27458237, PubMed:27591049).

Regulates innate immunity by restricting linear polyubiquitin formation on RIPK2 in response to NOD2 stimulation (PubMed:26997266).

Involved in TNF-alpha-induced necroptosis by removing linear ('Met-1'-linked) polyubiquitin chains from RIPK1, thereby regulating the kinase activity of RIPK1 (By similarity).

Removes 'Lys-63' linked polyubiquitin chain of MAP3K7, which inhibits phosphorylation and blocks downstream activation of the JNK-p38 kinase cascades (PubMed:29291351).
Biological Process
Cell cycle Source: UniProtKB-KW
Innate immune response Source: UniProtKB
Necroptotic process Source: GO_Central
Negative regulation of canonical Wnt signaling pathway Source: UniProtKB
Negative regulation of JNK cascade Source: UniProtKB
Negative regulation of NF-kappaB transcription factor activity Source: UniProtKB
Negative regulation of NIK/NF-kappaB signaling Source: UniProtKB
Negative regulation of p38MAPK cascade Source: UniProtKB
Negative regulation of type I interferon production Source: Reactome
Nucleotide-binding oligomerization domain containing signaling pathway Source: Reactome
Positive regulation of extrinsic apoptotic signaling pathway Source: UniProtKB
Protein deubiquitination Source: UniProtKB
Protein K63-linked deubiquitination Source: UniProtKB
Protein linear deubiquitination Source: UniProtKB
Regulation of cilium assembly Source: UniProtKB
Regulation of inflammatory response Source: UniProtKB
Regulation of intrinsic apoptotic signaling pathway Source: UniProtKB
Regulation of microtubule cytoskeleton organization Source: UniProtKB
Regulation of mitotic cell cycle Source: UniProtKB
Regulation of necroptotic process Source: UniProtKB
Regulation of tumor necrosis factor-mediated signaling pathway Source: UniProtKB
Ubiquitin-dependent protein catabolic process Source: InterPro
Wnt signaling pathway Source: UniProtKB-KW
Cellular Location
Cell membrane; Cytoskeleton; Centrosome; Spindle; Cilium basal body; Cytoplasm; Perinuclear region. Detected at the microtubule cytoskeleton during interphase. Detected at the midbody during telophase. During metaphase, it remains localized to the centrosome but is also present along the spindle (PubMed:25134987).
Involvement in disease
Cylindromatosis, familial (FCYL):
A disorder characterized by multiple skin tumors that develop from skin appendages, such as hair follicles and sweat glands. Affected individuals typically develop large numbers of tumors called cylindromas that arise predominantly in hairy parts of the body with approximately 90% on the head and neck. In severely affected individuals, cylindromas may combine into a confluent mass which may ulcerate or become infected (turban tumor syndrome). Individuals with familial cylindromatosis occasionally develop other types of tumors including spiradenomas that begin in sweat glands, and trichoepitheliomas arising from hair follicles.
Multiple familial trichoepithelioma 1 (MFT1):
Autosomal dominant dermatosis characterized by the presence of many skin tumors predominantly on the face. Since histologic examination shows dermal aggregates of basaloid cells with connection to or differentiation toward hair follicles, this disorder has been thought to represent a benign hamartoma of the pilosebaceous apparatus. Trichoepitheliomas can degenerate into basal cell carcinoma.
Brooke-Spiegler syndrome (BRSS):
An autosomal dominant disorder characterized by the appearance of multiple skin appendage tumors such as cylindroma, trichoepithelioma, and spiradenoma. These tumors are typically located in the head and neck region, appear in early adulthood, and gradually increase in size and number throughout life.
PTM
Ubiquitinated. Polyubiquitinated in hepatocytes treated with palmitic acid. Ubiquitination is mediated by E3 ligase TRIM47 and leads to proteasomal degradation.
Phosphorylated on several serine residues by IKKA and/or IKKB in response to immune stimuli. Phosphorylation requires IKBKG. Phosphorylation abolishes TRAF2 deubiquitination, interferes with the activation of Jun kinases, and strongly reduces CD40-dependent gene activation by NF-kappa-B.

Schott, M., Kappelmann‑Fenzl, M., Fischer, S., Fernandez‑Barrena, M. G., Pineda‑Lucena, A., Ávila, M. A., ... & Bosserhoff, A. K. (2022). Impact of CYLD on chromatin structure and histone methylation in malignant melanoma. International Journal of Molecular Medicine, 49(5), 1-13.

Cui, Z., Kang, H., Grandis, J. R., & Johnson, D. E. (2021). CYLD Alterations in the Tumorigenesis and Progression of Human Papillomavirus–Associated Head and Neck Cancers. Molecular Cancer Research, 19(1), 14-24.

Colombo, E., Horta, G., Roesler, M. K., Ihbe, N., Chhabra, S., Radyushkin, K., ... & Schmeisser, M. J. (2021). The K63 deubiquitinase CYLD modulates autism-like behaviors and hippocampal plasticity by regulating autophagy and mTOR signaling. Proceedings of the National Academy of Sciences, 118(47).

Deng, M., Dai, W., Yu, V. Z., Tao, L., & Lung, M. L. (2020). Cylindromatosis Lysine 63 Deubiquitinase (CYLD) regulates NF-kB signaling pathway and modulates fibroblast and endothelial cells recruitment in nasopharyngeal carcinoma. Cancers, 12(7), 1924.

Dobson-Stone, C., Hallupp, M., Shahheydari, H., Ragagnin, A. M., Chatterton, Z., Carew-Jones, F., ... & Kwok, J. B. (2020). CYLD is a causative gene for frontotemporal dementia–amyotrophic lateral sclerosis. Brain, 143(3), 783-799.

Zhu, G., Herlyn, M., & Yang, X. (2021). TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination. Nature Cell Biology, 23(9), 978-991.

Tábuas-Pereira, M., Santana, I., Kun-Rodrigues, C., Bras, J., & Guerreiro, R. (2020). CYLD variants in frontotemporal dementia associated with severe memory impairment in a Portuguese cohort. Brain, 143(8), e67-e67.

Tang, Y., Reissig, S., Glasmacher, E., Regen, T., Wanke, F., Nikolaev, A., ... & Waisman, A. (2019). Alternative splice forms of CYLD mediate ubiquitination of SMAD7 to prevent TGFB signaling and promote colitis. Gastroenterology, 156(3), 692-707.

Chen, Y., & Yang, C. (2018). miR‑197‑3p‑induced downregulation of lysine 63 deubiquitinase promotes cell proliferation and inhibits cell apoptosis in lung adenocarcinoma cell lines. Molecular Medicine Reports, 17(3), 3921-3927.

Hajek, M., Sewell, A., Kaech, S., Burtness, B., Yarbrough, W. G., & Issaeva, N. (2017). TRAF3/CYLD mutations identify a distinct subset of human papillomavirus‐associated head and neck squamous cell carcinoma. Cancer, 123(10), 1778-1790.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-CYLD Recombinant Antibody (1E9)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare